2023. 8. 7, 코리아 헤럴드

Efforts are underway to consider sex differences in drug development by increasing woman’s participation in clinical trials, but the lack of regulatory guidelines remains a barrier to taking gender diversity into account, experts say.

기사 보기 (영문)  >>